Âé¶¹´«Ã½Ó³»­

Âé¶¹´«Ã½Ó³»­

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

CSF biomarkers predict long term improvement after shunt surgery for Idiopathic Normal Pressure Hydrocephalus
Aging, Dementia, and Behavioral Neurology
Aging and Dementia Posters (7:00 AM-5:00 PM)
097
To determine whether CSF biomarkers, along with cognitive and gait measures, can determine long-term outcomes in iNPH. 

Idiopathic normal pressure hydrocephalus (iNPH) is a potentially reversible neurologic condition, however, distinguishing it from other neurodegenerative aging changes remains a challenge. While CSF biomarkers of neurodegeneration have been proposed to distinguish iNPH from these confounders, existing studies have been limited and none have any long-term outcomes.  

CSF was obtained from iNPH patients during a standard of care large volume lumbar puncture (LVLP).  Cognitive and gait assessments were performed before and after the procedure. Patients were deemed to be responders and referred for shunt surgery based on iNPH guidelines. Shunted patients were seen in clinic, with gait assessments at periodic intervals following surgery. CSF NFL, Aβ1-40, Aβ1-42, tTau, pTau181, and LRG were measured using digital, electrochemiluminescence and colorimetric ELISAs.   

Higher NFL, pTau181, tTau but lower Aβ1-40 are predictive of worse long-term gait outcomes after shunt surgery. NFL was proven to be the best single predictor of patient response after shunt surgery; however, the greatest potential lies in combining multiple biomarkers.  A multivariate model of NFL with pTau181, Aβ1-40 and tTau along with age and MRI Evan’s index improve predictions further (AUC 0.82[0.74-0.91]). tTau, pTau181 and Aβ1-40 were statistically different in those whose gait improved after a LVLP vs. those who did not improve. 

While pTau181, tTau and Aβ1-40 were statistically different in LVLP responder vs non-responder, they did not significantly increase the prediction provided by the MRI Evan’s index. In contrast, NFL in combination with these biomarkers, were stong predictors of long-term gait outcomes post shunt surgery. Therefore, combination of CSF biomarkers can be used in counseling patients of the expected long-term gait outcomes following surgery. This study cannot distinguish whether comorbidity or neurodegeneration, caused by iNPH itself, correlates with CSF biomarkers. 

Authors/Disclosures
Alexandria E. Lewis (Johns Hopkins University)
PRESENTER
Alexandria Lewis has nothing to disclose.
No disclosure on file
Abhay Moghekar, MD (Johns Hopkins Bayview Medical Center) Dr. Moghekar has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Deluca and Weizenbaum. Dr. Moghekar has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Silver Golub and Tieteel. The institution of Dr. Moghekar has received research support from NIH. Dr. Moghekar has a non-compensated relationship as a Medical Advisory Board member with Hydrocephalus Association that is relevant to Âé¶¹´«Ã½Ó³»­ interests or activities. Dr. Moghekar has a non-compensated relationship as a Medical Advisory Board member with Spinal CSF Leak Foundation that is relevant to Âé¶¹´«Ã½Ó³»­ interests or activities.